WHO ICTRP trial
Colchicine for the Primary Prevention of Atrial Fibrillation after Cardiac…
ACTRN12613001345774 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12613001345774 |
|---|---|
| Public title | Colchicine for the Primary Prevention of Atrial Fibrillation after Cardiac Surgery: A Double Blind Placebo Randomised Controlled Trial |
| Scientific title | Colchicine for the Primary Prevention of Atrial Fibrillation after Cardiac Surgery: A Double Blind Placebo Randomised Controlled Trial |
| Primary sponsor | Barwon Health - The Geelong Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia |
| Conditions | Postoperative Atrial Fibrillation after Cardiac Surgery; Postoperative Atrial Fibrillation after Cardiac Surgery;Cardiovascular - Other cardiovascular diseases |
| Interventions | Colchicine 0.5 mg oral twice daily for 7 days or until discharge (whichever occurs sooner). |
| Registration date | Sep 12, 2013 |
| Target size | 520 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: